Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Access to Health Services

  • your selections
Clear Search

Filter Results

date

Tags

  • results
NPR’s Morning Edition Examines Global Health Initiative

NPR’s Morning Edition examines the Obama administration’s Global Health Initiative (GHI) and efforts to combat HIV/AIDS. The $63 billion dollar “initiative preserves the Bush AIDS relief plan,” known as PEPFAR, and aims “to allow patients to get care at one location rather than having to seek care at different places. For example, family planning at one facility and HIV care at another,” NPR notes.

Also In Global Health News: India’s Right To Information Law; Flu Treatment Study; Haiti Food Aid; U.S. Commits $88M To Zambia; Measles In Africa

New York Times Examines India’s Right To Information Law The New York Times examines India’s Right to Information law and how it has “newly empowered” the country’s poor. The law enables citizens to file requests for information on pending housing stipends, government pensions or “almost any information from the government,” according…

Obama Administration Names Eight ‘GHI Plus’ Countries

“The Obama administration has selected eight countries to serve as learning labs for a new global health strategy aimed in part at reducing maternal and child deaths and combatting preventable diseases,” the Wall Street Journal reports. “The move is among the first steps in the administration’s” roll-out of the Global Health Initiative (GHI) and “comes amid mounting concerns about how much support President Barack Obama will win from Congress for a proposed 9% increase in global health spending for fiscal 2011,” the newspaper reports.

WCO Signs Declaration, Vows To Crack Down On Counterfeit Drug Industry

World Customs Organization (WCO) Secretary General Kunio Mikuriya on Thursday signed a declaration vowing his group’s commitment to crack down on the counterfeit drug industry, PBS NewsHour’s “The Rundown” blog reports. The piece examines the growing threat of counterfeit medications and efforts to clamp down on the distribution of such drugs (Miller, 6/24).